Immune Response to Mucosal Infection.

Rubén López-Santiago, Ana Beatriz Sánchez-Argáez, Liliana Gabriela De Alba-Núñez, Shantal Lizbeth Baltierra-Uribe, Martha Cecilia Moreno-Lafont
Author Information
  1. Rubén López-Santiago: Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.
  2. Ana Beatriz Sánchez-Argáez: Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.
  3. Liliana Gabriela De Alba-Núñez: Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.
  4. Shantal Lizbeth Baltierra-Uribe: Departamento de Microbiología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.
  5. Martha Cecilia Moreno-Lafont: Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.

Abstract

Brucellosis is one of the most prevalent bacterial zoonosis of worldwide distribution. The disease is caused by spp., facultative intracellular pathogens. Brucellosis in animals results in abortion of fetuses, while in humans, it frequently manifests flu-like symptoms and a typical undulant fever, being osteoarthritis a common complication of the chronic infection. The two most common ways to acquire the infection in humans are through the ingestion of contaminated dairy products or by inhalation of contaminated aerosols. spp. enter the body mainly through the gastrointestinal and respiratory mucosa; however, most studies of immune response to spp. are performed analyzing models of systemic immunity. It is necessary to better understand the mucosal immune response induced by infection since this is the main entry site for the bacterium. In this review, some virulence factors and the mechanisms needed for pathogen invasion and persistence are discussed. Furthermore, some aspects of local immune responses induced during infection will be reviewed. With this knowledge, better vaccines can be designed focused on inducing protective mucosal immune response.

Keywords

References

  1. Mol Microbiol. 1999 Jun;32(6):1198-211 [PMID: 10383761]
  2. Clin Diagn Lab Immunol. 1999 Sep;6(5):760-4 [PMID: 10473532]
  3. Infect Immun. 2000 Jun;68(6):3286-9 [PMID: 10816475]
  4. Appl Environ Microbiol. 2000 Jun;66(6):2502-12 [PMID: 10831430]
  5. Infect Immun. 2000 Jul;68(7):3927-32 [PMID: 10858205]
  6. Infect Immun. 2000 Jul;68(7):4102-7 [PMID: 10858227]
  7. Infect Immun. 2001 Jul;69(7):4528-35 [PMID: 11401996]
  8. Infect Immun. 2001 Sep;69(9):5502-8 [PMID: 11500423]
  9. Immunology. 2001 Aug;103(4):511-8 [PMID: 11529943]
  10. Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):1-3 [PMID: 11782541]
  11. Appl Environ Microbiol. 2002 Feb;68(2):910-6 [PMID: 11823235]
  12. Eur J Immunol. 2002 May;32(5):1282-91 [PMID: 11981815]
  13. Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12375-80 [PMID: 12218183]
  14. Vet Microbiol. 2002 Dec 20;90(1-4):281-97 [PMID: 12414149]
  15. Vet Microbiol. 2002 Dec 20;90(1-4):479-96 [PMID: 12414166]
  16. Clin Microbiol Rev. 2003 Jan;16(1):65-78 [PMID: 12525425]
  17. Infect Immun. 2003 Apr;71(4):1887-96 [PMID: 12654805]
  18. Infect Immun. 2003 Jun;71(6):3261-71 [PMID: 12761107]
  19. Clin Exp Immunol. 2003 Jun;132(3):393-400 [PMID: 12780684]
  20. J Exp Med. 2003 Jul 7;198(1):5-17 [PMID: 12847134]
  21. Trends Microbiol. 2004 Mar;12(3):129-34 [PMID: 15001189]
  22. Vet Res. 2004 Jan-Feb;35(1):1-38 [PMID: 15099501]
  23. Best Pract Res Clin Gastroenterol. 2004 Apr;18(2):387-404 [PMID: 15123077]
  24. J Drug Target. 2003;11(8-10):489-93 [PMID: 15203917]
  25. Infect Immun. 2004 Jul;72(7):4031-9 [PMID: 15213148]
  26. Immunology. 2004 Sep;113(1):15-22 [PMID: 15312131]
  27. Vet Microbiol. 2004 Sep 8;102(3-4):237-45 [PMID: 15327798]
  28. Ann Acad Med Singapore. 2004 Jul;33(4 Suppl):27-30 [PMID: 15389303]
  29. Nat Rev Immunol. 2004 Dec;4(12):953-64 [PMID: 15573130]
  30. Curr Opin Microbiol. 2005 Feb;8(1):60-6 [PMID: 15694858]
  31. Nat Immunol. 2005 Apr;6(4):353-60 [PMID: 15785761]
  32. Nat Med. 2005 Apr;11(4 Suppl):S45-53 [PMID: 15812489]
  33. Br J Nutr. 2005 Apr;93 Suppl 1:S41-8 [PMID: 15877894]
  34. Nat Immunol. 2005 Jun;6(6):618-25 [PMID: 15880113]
  35. J Bacteriol. 2005 Aug;187(16):5631-9 [PMID: 16077108]
  36. Infect Immun. 1992 Jul;60(7):2863-9 [PMID: 1612752]
  37. J R Soc Med. 2005 Oct;98(10):451-4 [PMID: 16199812]
  38. Acta Paediatr Suppl. 2005 Oct;94(449):74-83 [PMID: 16214770]
  39. Infect Immun. 2005 Dec;73(12):8418-24 [PMID: 16299342]
  40. Expert Rev Vaccines. 2005 Dec;4(6):915-28 [PMID: 16372886]
  41. Nat Rev Immunol. 2006 Feb;6(2):148-58 [PMID: 16491139]
  42. Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4333-4 [PMID: 16537368]
  43. Microbes Infect. 2006 Apr;8(5):1277-86 [PMID: 16697684]
  44. Microbiol Immunol. 2006;50(6):421-7 [PMID: 16785713]
  45. Infect Immun. 2006 Jul;74(7):3874-9 [PMID: 16790759]
  46. Cell Mol Life Sci. 2006 Oct;63(19-20):2229-36 [PMID: 16964579]
  47. Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16514-9 [PMID: 17053080]
  48. Infect Immun. 2007 Jan;75(1):299-305 [PMID: 17088355]
  49. Infect Immun. 2007 Feb;75(2):774-80 [PMID: 17101645]
  50. J Immunol. 2007 Mar 1;178(5):2661-5 [PMID: 17312107]
  51. J Proteome Res. 2007 Apr;6(4):1519-29 [PMID: 17343405]
  52. Cell Microbiol. 2007 Jul;9(7):1851-69 [PMID: 17441987]
  53. BMC Microbiol. 2007 Jun 19;7:57 [PMID: 17578575]
  54. PLoS One. 2007 Jul 18;2(7):e631 [PMID: 17637846]
  55. J Immunol. 2007 Sep 1;179(5):2748-57 [PMID: 17709488]
  56. Clin Vaccine Immunol. 2007 Oct;14(10):1296-301 [PMID: 17715332]
  57. PLoS Pathog. 2008 Feb 8;4(2):e21 [PMID: 18266466]
  58. Best Pract Res Clin Gastroenterol. 2008;22(3):391-409 [PMID: 18492562]
  59. J Immunol. 2008 Sep 1;181(5):3456-63 [PMID: 18714018]
  60. Nat Rev Microbiol. 2008 Dec;6(12):883-92 [PMID: 18955984]
  61. Infect Immun. 2009 Feb;77(2):877-84 [PMID: 19047401]
  62. Vet Microbiol. 1991 Jul;28(2):171-88 [PMID: 1908158]
  63. Adv Immunol. 2008;99:115-63 [PMID: 19117534]
  64. Annu Rev Immunol. 2009;27:485-517 [PMID: 19132915]
  65. Nat Rev Microbiol. 2009 Mar;7(3):250; author reply 250 [PMID: 19172149]
  66. Clin Vaccine Immunol. 2009 May;16(5):779-83 [PMID: 19321692]
  67. Semin Immunol. 2009 Jun;21(3):164-71 [PMID: 19386512]
  68. Microbes Infect. 2009 Apr;11(4):476-83 [PMID: 19397873]
  69. Mucosal Immunol. 2009 Jul;2(4):284-7 [PMID: 19421181]
  70. Infect Immun. 2009 Oct;77(10):4197-208 [PMID: 19651862]
  71. Vaccine. 2009 Nov 12;27(48):6704-11 [PMID: 19748579]
  72. Microbes Infect. 2010 Jan;12(1):3-10 [PMID: 19772948]
  73. Infect Immun. 2010 May;78(5):2283-91 [PMID: 20194591]
  74. BMC Microbiol. 2010 Apr 10;10:107 [PMID: 20380737]
  75. Immunology. 2010 Mar;129(3):311-21 [PMID: 20409152]
  76. Prilozi. 2010;31(1):21-32 [PMID: 20703181]
  77. J Bacteriol. 2010 Nov;192(21):5603-8 [PMID: 20833814]
  78. Eur J Immunol. 2010 Dec;40(12):3458-71 [PMID: 21108467]
  79. Vaccine. 2011 Jan 17;29(4):784-94 [PMID: 21109033]
  80. PLoS One. 2011 Jan 14;6(1):e16203 [PMID: 21264260]
  81. Vaccine. 2011 Mar 24;29(15):2749-55 [PMID: 21316499]
  82. Anim Health Res Rev. 2011 Jun;12(1):113-21 [PMID: 21676343]
  83. PLoS One. 2011;6(7):e21978 [PMID: 21765931]
  84. Infect Immun. 2011 Oct;79(10):4165-74 [PMID: 21768283]
  85. Clin Vaccine Immunol. 2012 Feb;19(2):249-60 [PMID: 22169089]
  86. Clin Dev Immunol. 2012;2012:589494 [PMID: 22194770]
  87. Vaccine. 2012 Feb 8;30(7):1283-90 [PMID: 22222868]
  88. Clin Dev Immunol. 2012;2012:352493 [PMID: 22242036]
  89. FEMS Microbiol Rev. 2012 May;36(3):533-62 [PMID: 22373010]
  90. FEMS Immunol Med Microbiol. 2012 Oct;66(1):45-57 [PMID: 22553918]
  91. PLoS Pathog. 2012;8(5):e1002675 [PMID: 22589715]
  92. J Immunol. 2012 Aug 15;189(4):1540-4 [PMID: 22772447]
  93. Sci Rep. 2012;2:495 [PMID: 22773944]
  94. J Infect Dis. 2012 Nov;206(9):1424-32 [PMID: 22930809]
  95. PLoS Pathog. 2012;8(11):e1002983 [PMID: 23166489]
  96. Hum Vaccin Immunother. 2013 Apr;9(4):805-7 [PMID: 23322214]
  97. Infect Immun. 1990 Jun;58(6):1992-4 [PMID: 2341188]
  98. Can J Infect Dis Med Microbiol. 2012 Spring;23(1):e13-5 [PMID: 23449236]
  99. Vet Microbiol. 2013 Jun 28;164(3-4):322-9 [PMID: 23507429]
  100. Front Biol (Beijing). 2013 Feb 1;8(1):60-77 [PMID: 23730309]
  101. PLoS Pathog. 2013;9(6):e1003454 [PMID: 23818855]
  102. J Clin Microbiol. 2013 Sep;51(9):3055-62 [PMID: 23824774]
  103. Rev Sci Tech. 2013 Apr;32(1):17-25 [PMID: 23837362]
  104. Vaccine. 2013 Aug 28;31(38):4103-10 [PMID: 23845817]
  105. Biomed Res Int. 2013;2013:743509 [PMID: 23862154]
  106. Pathog Dis. 2013 Dec;69(3):194-204 [PMID: 23893966]
  107. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Nov;116(5):576-83 [PMID: 24119522]
  108. World J Gastrointest Pathophysiol. 2013 Nov 15;4(4):94-9 [PMID: 24244877]
  109. Biochemistry. 2013 Dec 23;52(51):9385-93 [PMID: 24308818]
  110. Curr Pharm Biotechnol. 2013;14(10):887-96 [PMID: 24372253]
  111. PLoS One. 2014 Jul 01;9(7):e101279 [PMID: 24983999]
  112. PLoS One. 2014 Sep 16;9(9):e107180 [PMID: 25225910]
  113. Nat Rev Immunol. 2014 Oct;14(10):667-85 [PMID: 25234148]
  114. Arch Microbiol. 2015 Jan;197(1):1-10 [PMID: 25294190]
  115. Appl Environ Microbiol. 2015 Jan;81(2):578-86 [PMID: 25381237]
  116. PLoS One. 2015 Apr 28;10(4):e0121790 [PMID: 25919005]
  117. Philos Trans R Soc Lond B Biol Sci. 2015 Jun 19;370(1671):null [PMID: 25964464]
  118. Vet Res. 2015 Jul 08;46:76 [PMID: 26155935]
  119. Front Cell Infect Microbiol. 2015 Jun 24;5:54 [PMID: 26157707]
  120. Vet Res Commun. 2015 Dec;39(4):217-28 [PMID: 26395469]
  121. Cell Microbiol. 2016 Apr;18(4):500-13 [PMID: 26400021]
  122. PLoS One. 2015 Oct 08;10(10):e0140408 [PMID: 26448160]
  123. J Control Release. 2015 Dec 28;220(Pt A):18-28 [PMID: 26456256]
  124. J Bacteriol. 2015 Dec;197(24):3834-47 [PMID: 26459556]
  125. Front Cell Infect Microbiol. 2015 Oct 13;5:72 [PMID: 26528442]
  126. Annu Rev Anim Biosci. 2016;4:111-27 [PMID: 26734887]
  127. PLoS Pathog. 2016 Jan 07;12(1):e1005295 [PMID: 26742105]
  128. Immunol Cell Biol. 2016 May;94(5):496-508 [PMID: 26752510]
  129. J Biol Chem. 2016 Apr 1;291(14):7727-41 [PMID: 26867577]
  130. J Immunol. 2016 May 1;196(9):3780-93 [PMID: 27036913]
  131. Front Microbiol. 2016 Apr 20;7:550 [PMID: 27148232]
  132. Vet Immunol Immunopathol. 2016 Oct 1;178:50-6 [PMID: 27496742]
  133. PLoS Negl Trop Dis. 2016 Aug 18;10(8):e0004572 [PMID: 27537413]
  134. Curr Opin Microbiol. 2017 Feb;35:1-7 [PMID: 27621139]
  135. PLoS One. 2016 Sep 16;11(9):e0157875 [PMID: 27636704]
  136. Vaccine. 2016 Oct 17;34(44):5290-5297 [PMID: 27639282]
  137. Expert Rev Anti Infect Ther. 2017 Jan;15(1):33-42 [PMID: 27790937]
  138. J Clin Periodontol. 2017 Dec;44(12):1215-1225 [PMID: 28727164]
  139. J Vet Sci. 2017 Aug 31;18(S1):281-290 [PMID: 28859268]
  140. PLoS One. 2017 Oct 12;12(10):e0186484 [PMID: 29023541]
  141. Vet Immunol Immunopathol. 2018 Jan;195:40-45 [PMID: 29249316]
  142. Int J Nanomedicine. 2017 Dec 13;12:8769-8778 [PMID: 29263667]
  143. Mol Immunol. 2018 Mar;95:114-121 [PMID: 29433066]
  144. Vaccine. 2018 Mar 27;36(14):1837-1845 [PMID: 29486945]
  145. J S Afr Vet Assoc. 2018 Mar 29;89(0):e1-e7 [PMID: 29781672]
  146. Transbound Emerg Dis. 2019 Jan;66(1):505-516 [PMID: 30375177]
  147. Front Cell Infect Microbiol. 2018 Nov 05;8:391 [PMID: 30456207]
  148. Mol Med Rep. 2019 Feb;19(2):1302-1308 [PMID: 30569140]
  149. Vaccine. 2019 Feb 8;37(7):899-902 [PMID: 30661832]
  150. Anim Biotechnol. 2019 Feb 5;:1-7 [PMID: 30717621]
  151. PLoS One. 2019 Mar 5;14(3):e0212457 [PMID: 30835758]
  152. PLoS One. 2019 Mar 11;14(3):e0213587 [PMID: 30856219]
  153. Infect Immun. 2019 May 21;87(6): [PMID: 30936160]
  154. Adv Exp Med Biol. 1994;355:295-301 [PMID: 7709839]
  155. Infect Immun. 1995 Apr;63(4):1387-90 [PMID: 7890399]
  156. Microbiol Rev. 1994 Jun;58(2):145-61 [PMID: 8078434]
  157. J Exp Med. 1996 Oct 1;184(4):1449-59 [PMID: 8879216]
  158. J Immunol. 1998 Aug 1;161(3):1447-53 [PMID: 9686610]
  159. Int J Food Microbiol. 1998 May 26;41(2):155-67 [PMID: 9704864]
  160. J Bacteriol. 1998 Sep;180(17):4392-400 [PMID: 9721274]
  161. Infect Immun. 1998 Nov;66(11):5485-93 [PMID: 9784561]
  162. Infect Immun. 1998 Dec;66(12):5711-24 [PMID: 9826346]

MeSH Term

Brucella
Brucellosis
Humans
Immunity, Mucosal
Intestinal Mucosa
Respiratory Mucosa
Virulence

Word Cloud

Created with Highcharts 10.0.0infectionimmunesppresponseimmunityBrucellosisintracellularhumanscommoncontaminatedrespiratorybettermucosalinducedvaccinesoneprevalentbacterialzoonosisworldwidedistributiondiseasecausedfacultativepathogensanimalsresultsabortionfetusesfrequentlymanifestsflu-likesymptomstypicalundulantfeverosteoarthritiscomplicationchronictwowaysacquireingestiondairyproductsinhalationaerosolsenterbodymainlygastrointestinalmucosahoweverstudiesperformedanalyzingmodelssystemicnecessaryunderstandsincemainentrysitebacteriumreviewvirulencefactorsmechanismsneededpathogeninvasionpersistencediscussedFurthermoreaspectslocalresponseswillreviewedknowledgecandesignedfocusedinducingprotectiveImmuneResponseMucosalInfectionBrucellabrucellosisguttract

Similar Articles

Cited By